The care pathway
Diagnosis
Accurate staging & risk grouping
Treatment
Standardized, evidence-based protocols
Follow-up
Structured surveillance schedules
Survivorship
Long-term health & quality of life
Guidelines & management programs
Current clinical practice guidelines
SWENOTECA X
Treatment algorithms and risk-adapted protocols for seminoma and non-seminoma germ cell tumours.
Follow-up programme
Surveillance schedules and imaging intervals by stage and risk group.
Forms & eCRF
Registration forms and the Ledidi electronic case report form for trial data.
Final visit & survivor care plan
Discharge documentation and long-term survivorship care planning.
Patient information
Plain-language material for patients on diagnosis, treatment and follow-up.
Archived programs
Earlier management programs retained for reference and historical context.
Latest
News & announcements
Active studies
Research that changes practice
Prospective
The ABC-study
Active surveillance and risk-adapted treatment in clinical stage I germ cell tumours, with quality-of-life endpoints.
Learn more →Now open
The TESTIGO-study
Newly opened: an international collaborative trial in testicular germ cell cancer, now enrolling across the Nordic centres.
Learn more →Collaborative
Other studies
Collaborative trials and registry analyses across the Nordic treatment centres and partners.
Learn more →Stay informed
Join the SWENOTECA mailing list
Receive guideline updates, meeting invitations and study news directly to your inbox.
Join the mailing list →
Guideline updates, meeting invitations & study news · unsubscribe at any time.